ALK/ROS1 rearrangements: A real hallmark for thromboembolic events in cancer patients?

被引：6
|
作者：
Nichetti, Federico [1 ]
Lo Russo, Giuseppe [1 ]
Prelaj, Arsela [1 ]
Provenzano, Leonardo [1 ]
de Braud, Filippo [1 ,2 ]
Cabiddu, Mary [3 ]
Garassino, Marina Chiara [1 ]
Petrelli, Fausto [3 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Via Venezian 1, I-20133 Milan, Italy
[2] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy
[3] ASST Bergamo Ovest, Med Oncol Unit, I-24047 Treviglio, BG, Italy
来源：
THROMBOSIS RESEARCH | 2020年 / 194卷
关键词：
Non-Small-Cell Lung Cancer; Thromboembolic events; Thrombosis; ALK; ROS-1; Tyrosine kinase inhibitors; VENOUS THROMBOEMBOLISM;
D O I：
10.1016/j.thromres.2020.06.041
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：176 / 177
页数：2
相关论文
共 50 条
  • [21] Screening of NSCLC samples from Chinese lung cancer patients for activating rearrangements of the ALK, RET, and ROS1 genes.
    Zheng, Li-Mou
    Whyte, David B.
    Ruan, Li
    Song, Roman
    Fei, Luo
    Yang, Nancy
    Zhou, Caicun
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare
    Zhao, Weijie
    Choi, Yoon-La
    Song, Ji-Young
    Zhu, Yazhen
    Xu, Qing
    Zhang, Feng
    Jiang, Lili
    Cheng, Ju
    Zheng, Guangjuan
    Mao, Mao
    LUNG CANCER, 2016, 94 : 22 - 27
  • [23] Detection of EGFR Mutations, ALK, and ROS1 Rearrangements in Cytological Specimens: An Institutional Experience
    Naous, Rana
    Zhang, Shengle
    Khurana, Kamal K.
    MODERN PATHOLOGY, 2016, 29 : 111A - 111A
  • [24] Detection of EGFR Mutations, ALK, and ROS1 Rearrangements in Cytological Specimens: An Institutional Experience
    Naous, Rana
    Zhang, Shengle
    Khurana, Kamal K.
    LABORATORY INVESTIGATION, 2016, 96 : 111A - 111A
  • [25] ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours
    Yamamoto, Hidetaka
    Yoshida, Akihiko
    Taguchi, Kenichi
    Kohashi, Kenichi
    Hatanaka, Yui
    Yamashita, Atsushi
    Mori, Daisuke
    Oda, Yoshinao
    HISTOPATHOLOGY, 2016, 69 (01) : 72 - 83
  • [26] ROS1: Rearrangements und Analytik
    Siebolts, Udo
    Merkelbach-Bruse, Sabine
    PATHOLOGIE, 2023, 44 (01): : 50 - 52
  • [27] Detection of ALK and ROS1 Rearrangements Using Next Generation Sequencing in Lung Cancer Patients: Comparison Between FISH, IHC and NGS
    Clave, Sergi
    Rodon, Natalia
    Pijuan, Lara
    Dalmases, Alba
    Taus, Alvaro
    Lorenzo, Marta
    Rocha, Pedro
    Munoz-Marmol, Ana M.
    Oliveras, Gloria
    Bosch-Barrera, Joaquim
    Espinet, Blanca
    Bellosillo, Beatriz
    Puig Torrus, Xavier
    Arriola, Edurne
    Salido, Marta
    MODERN PATHOLOGY, 2018, 31 : 729 - 729
  • [28] Detection of ALK and ROS1 Rearrangements Using Next Generation Sequencing in Lung Cancer Patients: Comparison Between FISH, IHC and NGS
    Clave, Sergi
    Rodon, Natalia
    Pijuan, Lara
    Dalmases, Alba
    Taus, Alvaro
    Lorenzo, Marta
    Rocha, Pedro
    Munoz-Marmol, Ana M.
    Oliveras, Gloria
    Bosch-Barrera, Joaquim
    Espinet, Blanca
    Bellosillo, Beatriz
    Puig Torrus, Xavier
    Arriola, Edurne
    Salido, Marta
    LABORATORY INVESTIGATION, 2018, 98 : 729 - 729
  • [29] COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors
    Leonetti, Alessandro
    Facchinetti, Francesco
    Zielli, Teresa
    Brianti, Elena
    Tiseo, Marcello
    EUROPEAN JOURNAL OF CANCER, 2020, 132 : 122 - 124
  • [30] High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1
    Munoz-Unceta, Nerea
    Zugazagoitia, Jon
    Manzano, Arancha
    Jimenez-Aguilar, Elisabeth
    Olmedo, Maria E.
    Cacho, Juan D.
    Oliveira, Julio
    Domine, Manuel
    Ortega-Moran, Laura
    Aguado, Carlos
    Luna, Ana M.
    Fernandez, Lourdes
    Perez, Javier
    Font, Carme
    Salvador, Carmen
    Corral, Jesus
    Benitez, Gretel
    Ros, Silverio
    Biosca, Mercedes
    Calvo, Virginia
    Martinez, Julia
    Sanchez-Canovas, Manuel
    Lopez, Rafael
    Sereno, Maria
    Mielgo, Xabier
    Aparisi, Francisco
    Carmona, Marta
    Carrion, Rafael
    Ponce-Aix, Santiago
    Soares, Marta
    Martinez-Salas, Imanol
    Garcia-Morillo, Marcial
    Juan-Vidal, Oscar
    Blasco, Ana
    Munoz, Andres J.
    Paz-Ares, Luis
    EUROPEAN JOURNAL OF CANCER, 2020, 141 : 193 - 198
12345